Most importantly, GRN is not linked to any muscle disease and only published to be a minor risk factor for ALS [57, 58] and therefore not expected to affect SpMN axon outgrowth or muscle development but rather exclusively lead to NCL or FTLD-related phenotypes when mutated. This evidence concerns the gene GRN and amyotrophic lateral sclerosis.